Reference: 10166. 3 x 10 mL
The new generation of slow freezing – optimised composition, convenient protocol and high survival rate
Outstanding results:
Two independent studies show that survival of pronuclear stage oocytes and cleavage stage embryos is significantly improved using FreezeKit Cleave and ThawKit Cleave.
Significantly higher blastocyst survival:
GraphTwo clinics in Sweden made a pre-clinical, randomised comparison of FreezeKit Cleave and ThawKit Cleave with an existing commercial product for freezing of cleavage-stage embryos.
The primary endpoint was blastomere survival rate. A statistically significant difference in blastomere survival was seen between the two methods.
Significantly better survival rate:
At Westmead Fertility Center Australia, clinical use of FreezeKit Cleave and ThawKit Cleave resulted in improved survival. A retrospective analysis on 1497 embryos from 377 patients showed significantly better survival rate for both 2PN- and cleavage-stage embryos.
Safe to use for previously frozen material:
Survival of cleavage-stage embryos frozen with our older product, FREEZE-KIT 1, and thawed with the new ThawKit Cleave was 73%. This demonstrates the safety of the new procedure on previously frozen material.
Purpose: |
For freezing of pronuclear oocytes and cleavage stage embryos |
Description: |
MOPS buffered media |
Application: |
For use in sequence after equilibration at room temperature and ambient atmosphere |
Storage: |
Store dark at +2 to +8ºC |